News
![](https://www.carlislemedical.com/wp-content/uploads/2021/04/Picture5-e1618922566413.png)
![](https://www.carlislemedical.com/wp-content/uploads/2021/04/Picture5-e1618922566413.png)
Hysingla ER Generic Is Now Available
The generic formulation of Hysingla ER, hydrocodone bitartrate ER tablets, has been released by Alvogen….
Apr 06, 2021
![The U.S. DEA Proposes Production Cuts to Five Opioids in 2020](https://www.carlislemedical.com/wp-content/uploads/2019/09/DEA-Proposes-Production-Cuts-to-Five-Opioids.jpg)
![The U.S. DEA Proposes Production Cuts to Five Opioids in 2020](https://www.carlislemedical.com/wp-content/uploads/2019/09/DEA-Proposes-Production-Cuts-to-Five-Opioids.jpg)
The U.S. DEA Proposes Production Cuts to Five Opioids in 2020
The U.S. DEA (Drug Enforcement Administration) released a Notice of Proposed Rulemaking in the Federal…
Sep 16, 2019